Free Trial

Integra LifeSciences (IART) Competitors

Integra LifeSciences logo
$13.11 +0.40 (+3.15%)
Closing price 04:00 PM Eastern
Extended Trading
$13.12 +0.01 (+0.04%)
As of 04:29 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

IART vs. ATEC, ATRC, SRDX, OFIX, ANGO, ARAY, RMTI, RSLS, ABT, and ISRG

Should you be buying Integra LifeSciences stock or one of its competitors? The main competitors of Integra LifeSciences include Alphatec (ATEC), AtriCure (ATRC), Surmodics (SRDX), ORTHOFIX MEDICAL (OFIX), AngioDynamics (ANGO), Accuray (ARAY), Rockwell Medical (RMTI), ReShape Lifesciences (RSLS), Abbott Laboratories (ABT), and Intuitive Surgical (ISRG). These companies are all part of the "health care equipment" industry.

Integra LifeSciences vs. Its Competitors

Integra LifeSciences (NASDAQ:IART) and Alphatec (NASDAQ:ATEC) are both small-cap medical companies, but which is the superior investment? We will compare the two businesses based on the strength of their institutional ownership, dividends, risk, valuation, analyst recommendations, profitability, media sentiment and earnings.

Integra LifeSciences has a net margin of -1.78% compared to Alphatec's net margin of -25.77%. Integra LifeSciences' return on equity of 12.12% beat Alphatec's return on equity.

Company Net Margins Return on Equity Return on Assets
Integra LifeSciences-1.78% 12.12% 4.58%
Alphatec -25.77%-1,657.19%-21.53%

84.8% of Integra LifeSciences shares are owned by institutional investors. Comparatively, 66.4% of Alphatec shares are owned by institutional investors. 3.5% of Integra LifeSciences shares are owned by company insiders. Comparatively, 20.9% of Alphatec shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock will outperform the market over the long term.

Integra LifeSciences has a beta of 1.15, indicating that its share price is 15% more volatile than the S&P 500. Comparatively, Alphatec has a beta of 1.05, indicating that its share price is 5% more volatile than the S&P 500.

Integra LifeSciences currently has a consensus price target of $18.63, indicating a potential upside of 42.07%. Alphatec has a consensus price target of $18.13, indicating a potential upside of 67.51%. Given Alphatec's stronger consensus rating and higher possible upside, analysts clearly believe Alphatec is more favorable than Integra LifeSciences.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Integra LifeSciences
4 Sell rating(s)
3 Hold rating(s)
2 Buy rating(s)
0 Strong Buy rating(s)
1.78
Alphatec
0 Sell rating(s)
1 Hold rating(s)
8 Buy rating(s)
0 Strong Buy rating(s)
2.89

Integra LifeSciences has higher revenue and earnings than Alphatec. Integra LifeSciences is trading at a lower price-to-earnings ratio than Alphatec, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Integra LifeSciences$1.61B0.63-$6.94M-$0.38-34.50
Alphatec$611.56M2.59-$162.12M-$1.15-9.41

In the previous week, Integra LifeSciences and Integra LifeSciences both had 5 articles in the media. Integra LifeSciences' average media sentiment score of 0.86 beat Alphatec's score of 0.14 indicating that Integra LifeSciences is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Integra LifeSciences
1 Very Positive mention(s)
1 Positive mention(s)
2 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
Alphatec
1 Very Positive mention(s)
0 Positive mention(s)
2 Neutral mention(s)
0 Negative mention(s)
1 Very Negative mention(s)
Neutral

Summary

Integra LifeSciences beats Alphatec on 9 of the 15 factors compared between the two stocks.

Get Integra LifeSciences News Delivered to You Automatically

Sign up to receive the latest news and ratings for IART and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding IART and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

IART vs. The Competition

MetricIntegra LifeSciencesMED INSTRUMENTS IndustryMedical SectorNASDAQ Exchange
Market Cap$1.02B$7.00B$5.74B$9.51B
Dividend YieldN/A1.28%4.60%3.99%
P/E Ratio-34.5025.5128.1120.03
Price / Sales0.6366.31461.37103.88
Price / Cash2.8820.6736.5559.01
Price / Book0.654.758.655.90
Net Income-$6.94M$176.14M$3.25B$258.66M
7 Day Performance17.79%2.92%4.21%2.22%
1 Month Performance10.45%3.56%10.82%12.76%
1 Year Performance-58.42%7.66%34.70%19.36%

Integra LifeSciences Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
IART
Integra LifeSciences
4.1232 of 5 stars
$13.11
+3.1%
$18.63
+42.1%
-59.5%$1.02B$1.61B-34.504,396News Coverage
Upcoming Earnings
ATEC
Alphatec
3.904 of 5 stars
$10.91
-0.7%
$17.89
+64.0%
-1.8%$1.59B$642.27M-9.49700Upcoming Earnings
ATRC
AtriCure
3.3291 of 5 stars
$31.30
+1.9%
$50.67
+61.9%
+25.8%$1.55B$480.08M-38.641,300Positive News
Upcoming Earnings
SRDX
Surmodics
4.0139 of 5 stars
$31.39
+1.7%
$43.00
+37.0%
-23.3%$448.88M$126.08M-22.58450Positive News
Upcoming Earnings
OFIX
ORTHOFIX MEDICAL
2.744 of 5 stars
$10.98
-0.6%
$21.50
+95.8%
-33.6%$430.20M$799.49M-2.981,616Positive News
ANGO
AngioDynamics
3.9183 of 5 stars
$9.63
+3.3%
$14.00
+45.4%
+24.3%$391.05M$283.32M-9.53760High Trading Volume
ARAY
Accuray
3.0175 of 5 stars
$1.36
flat
N/A-29.4%$140.10M$465.25M0.001,040Positive News
RMTI
Rockwell Medical
3.9884 of 5 stars
$1.11
-1.8%
$4.00
+260.4%
-40.9%$37.93M$97.73M0.00300Positive News
RSLS
ReShape Lifesciences
0.4283 of 5 stars
$2.39
+0.4%
N/A-99.1%$5.71M$8.01M-0.0150Positive News
ABT
Abbott Laboratories
4.9902 of 5 stars
$132.05
+0.0%
$143.11
+8.4%
+17.2%$229.74B$42.34B17.13114,000
ISRG
Intuitive Surgical
4.6935 of 5 stars
$516.44
+0.9%
$592.86
+14.8%
+7.6%$185.10B$8.35B75.7215,638Trending News
Earnings Report
Analyst Forecast
Analyst Revision

Related Companies and Tools


This page (NASDAQ:IART) was last updated on 7/25/2025 by MarketBeat.com Staff
From Our Partners